This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lagas, J. S.
Right arrow Articles by Schinkel, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lagas, J. S.
Right arrow Articles by Schinkel, A. H.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 2008, p. 1034-1039, Vol. 52, No. 3
0066-4804/08/$08.00+0     doi:10.1128/AAC.01041-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

P-Glycoprotein Limits Oral Availability, Brain Penetration, and Toxicity of an Anionic Drug, the Antibiotic Salinomycin{triangledown}

Jurjen S. Lagas,1 Rolf W. Sparidans,3 Robert A. B. van Waterschoot,1 Els Wagenaar,1 Jos H. Beijnen,2 and Alfred H. Schinkel1*

Division of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam,1 Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam,2 Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands3

Received 8 August 2007/ Returned for modification 13 November 2007/ Accepted 2 January 2008

Salinomycin is a polyether organic anion that is extensively used as a coccidiostatic antibiotic in poultry and commonly fed to ruminant animals to improve feed efficiency. However, salinomycin also causes severe toxicity when accidentally fed to animals in high doses. In addition, humans are highly sensitive to salinomycin and severe toxicity has been reported. Multidrug efflux transporters like P-glycoprotein (P-gp), BCRP, and MRP2 are highly expressed in the intestine and can restrict the oral uptake and tissue penetration of xenobiotics. The purpose of this study was to investigate whether the anionic drug salinomycin is a substrate for one or more of these efflux pumps. Salinomycin was actively transported by human MDR1 P-gp expressed in polarized MDCK-II monolayers but not by the known organic anion transporters human MRP2 and murine Bcrp1. Using P-gp-deficient mice, we found a marked increase in plasma salinomycin concentrations after oral administration and decreased plasma clearance after intravenous administration. Furthermore, absence of P-gp resulted in significantly increased brain penetration. P-gp-deficient mice also displayed clearly increased susceptibility to salinomycin toxicity. Thus far, P-gp was thought to affect mainly hydrophobic, positively charged or neutral drugs in vivo. Our data show that P-gp can also be a major determinant of the pharmacokinetic behavior and toxicity of an organic anionic drug. Variation in P-gp activity might thus directly affect the effective exposure to salinomycin and possibly to other anionic drugs and toxin substrates. Individuals with reduced or absent P-gp activity could therefore be more susceptible to salinomycin toxicity.


* Corresponding author. Mailing address: Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. Phone: 31 20 512 2046. Fax: 31 20 512 2050. E-mail: a.schinkel{at}nki.nl

{triangledown} Published ahead of print on 14 January 2007.


Antimicrobial Agents and Chemotherapy, March 2008, p. 1034-1039, Vol. 52, No. 3
0066-4804/08/$08.00+0     doi:10.1128/AAC.01041-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Mols, R., Brouwers, J., Schinkel, A. H., Annaert, P., Augustijns, P. (2009). INTESTINAL PERFUSION WITH MESENTERIC BLOOD SAMPLING IN WILD-TYPE AND KNOCKOUT MICE: Evaluation of a Novel Tool in Biopharmaceutical Drug Profiling. Drug Metab. Dispos. 37: 1334-1337 [Abstract] [Full Text]